# The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients

> **NCT00316472** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 40 (—)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** Niacinamide

## Key facts

- **NCT ID:** NCT00316472
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-04
- **Final completion:** 2007-12
- **Target enrollment:** 40 (—)
- **Last updated:** 2009-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316472, "The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00316472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*